03/07/2026
March is Colon Cancer Awareness Month, an important time to highlight one of the most common and preventable cancers affecting adults.
🩸According to the National Cancer Institute, colon and re**al cancers represent roughly 7.6% of all new cancer cases nationwide and 8.6% of cancer deaths. Colore**al cancer (CRC) remains the third-leading cause of cancer-related deaths in the United States, with 154,270 new cases and 52,900 deaths in 2025
🩸The Shield™ test is a qualitative, in vitro diagnostic test intended to detect colore**al cancer derived alterations in cell-free DNA from blood collected in the Guardant Shield Blood Collection Kit.
🩸Shield is intended for colore**al cancer screening in individuals at average risk for the disease, age 45 years or older. Patients with a positive result should be followed by colonoscopy. Shield is not a replacement for diagnostic colonoscopy or for surveillance colonoscopy in high-risk individuals. This test is performed at Guardant Health, Inc.
🩸🩸For the month of March Sheild is offering anyone with commercial insurance or tri-care the sheild test for free. Medicare covers the cost all the time. 🩸🩸
Call the office to set up your appointment to be tested. 🎉🔥